How We Treat Drug-Susceptible Pulmonary Tuberculosis: A Practical Guide for Clinicians

被引：0
|
作者：
Riccardi, Niccolo [1 ,2 ]
Occhineri, Sara [1 ,2 ]
Vanino, Elisa [1 ,3 ]
Antonello, Roberta Maria [1 ]
Pontarelli, Agostina [1 ,4 ]
Saluzzo, Francesca [1 ,5 ]
Masini, Tiziana [1 ]
Besozzi, Giorgio [1 ]
Tadolini, Marina [1 ,6 ,7 ]
Codecasa, Luigi [1 ,8 ]
机构：
[1] StopTB Italia ODV, I-20159 Milan, Italy
[2] Univ Pisana, Azienda Osped Univ Pisana, Azienda Osped, I-56124 Pisa, Italy
[3] Santa Maria Croci Hosp, Infect Dis Unit, AUSL Romagna, I-48100 Ravenna, Italy
[4] Cotugno Hosp, Azienda Osped Colli, Unit Resp Infect Dis, I-80131 Naples, Italy
[5] San Raffaele Univ, IRCCS San Raffaele Sci Inst, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy
[6] Infect Dis Unit, IRCCS Azienda Osped Univ Bologna, I-40138 Bologna, Italy
[7] Alma Mater Studiorum Univ Bologna, Dept Med & Surg Sci, I-40138 Bologna, Italy
[8] ASST Grande Osped Metropolitano Niguarda, Villa Marelli Inst, Reg TB Reference Ctr, I-20159 Milan, Italy
来源：
ANTIBIOTICS-BASEL | 2023年 / 12卷 / 12期
关键词：
tuberculosis; pulmonary TB; drug susceptible; diagnosis; treatment; ANTITUBERCULOSIS DRUGS; DIABETES-MELLITUS; ADVERSE-REACTIONS; RISK-FACTORS; TB; RIFAMPIN; CARE; MANIFESTATIONS; HEPATOTOXICITY; PYRAZINAMIDE;
D O I：
10.3390/antibiotics12121733
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Tuberculosis (TB) remains one of the leading causes of morbidity and mortality worldwide and pulmonary TB (PTB) is the main variant responsible for fueling transmission of the infection. Effective treatment of drug-susceptible (DS) TB is crucial to avoid the emergence of Mycobacterium tuberculosis-resistant strains. In this narrative review, through a fictional suggestive case of DS PTB, we guide the reader in a step-by-step commentary to provide an updated review of current evidence in the management of TB, from diagnosis to post-treatment follow-up. World Health Organization and Centre for Diseases Control (CDC) guidelines for TB, as well as the updated literature, were used to support this manuscript.
引用
收藏
页数：17
相关论文
共 50 条
  • [1] Linezolid for drug-susceptible tuberculosis
    Han, Jiyeon
    Yim, Jae-Joon
    [J]. LANCET INFECTIOUS DISEASES, 2019, 19 (05): : 468 - 469
  • [2] Drug-susceptible tuberculosis - Reply
    Friedman, DR
    Quinn, GC
    Kreiswirth, BN
    Perlman, DC
    Saloman, N
    Schluger, N
    Lutfey, M
    Berger, J
    Poltoratskaia, N
    Riley, LW
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (04): : 1138 - 1139
  • [3] Treatment of Drug-Susceptible Tuberculosis
    Dela Cruz, Charles S.
    Lyons, Patrick G.
    Pasnick, Susan
    Weinstock, Tanya
    Nahid, Payam
    Wilson, Kevin C.
    Thomson, Carey C.
    [J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 (11) : 2060 - 2063
  • [4] Linezolid for drug-susceptible tuberculosis
    Bilgin, Huseyin
    Tukenmez-Tigen, Elif
    [J]. LANCET INFECTIOUS DISEASES, 2019, 19 (04): : 357 - 357
  • [5] Destroyed lung syndrome in patients with drug-susceptible pulmonary tuberculosis
    Gyabaah, Solomon
    Gyan, Kwadwo Faka
    Mensah, Harris Osei
    Darkwa, Eric Amoako
    Owiredu, Michael Asiedu
    Nyamuame, Vera Selorm
    Amponsah, Gordon Manu
    Amenuke, Divine Aseye
    [J]. CLINICAL CASE REPORTS, 2024, 12 (09):
  • [6] Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis
    Nahid, Payam
    Jarlsberg, Leah G.
    Rudoy, Irina
    de Jong, Bouke C.
    Unger, Alon
    Kawamura, L. Masae
    Osmond, Dennis H.
    Hopewell, Philip C.
    Daley, Charles L.
    [J]. BMC INFECTIOUS DISEASES, 2011, 11
  • [7] Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis
    Payam Nahid
    Leah G Jarlsberg
    Irina Rudoy
    Bouke C de Jong
    Alon Unger
    L Masae Kawamura
    Dennis H Osmond
    Philip C Hopewell
    Charles L Daley
    [J]. BMC Infectious Diseases, 11
  • [8] Risk-stratified treatment for drug-susceptible pulmonary tuberculosis
    Vincent K. Chang
    Marjorie Z. Imperial
    Patrick P. J. Phillips
    Gustavo E. Velásquez
    Payam Nahid
    Andrew Vernon
    Ekaterina V. Kurbatova
    Susan Swindells
    Richard E. Chaisson
    Susan E. Dorman
    John L. Johnson
    Marc Weiner
    Erin E. Sizemore
    William Whitworth
    Wendy Carr
    Kia E. Bryant
    Deron Burton
    Kelly E. Dooley
    Melissa Engle
    Pheona Nsubuga
    Andreas H. Diacon
    Nguyen Viet Nhung
    Rodney Dawson
    Radojka M. Savic
    [J]. Nature Communications, 15 (1)
  • [9] Risk of Treatment Failure in Patients with Drug-susceptible Pulmonary Tuberculosis in China
    WANG Ni
    MA Yan
    LIU YU Hong
    DU Jian
    ZHANG Hui
    XIE Shi Heng
    Zhu Kun
    LYU Xiao Ya
    SHU Wei
    WANG Hong Hong
    ZHU Guo Feng
    TAN Shou Yong
    FU Yan Yong
    MA Li Ping
    ZHANG Lian Ying
    LIU Fei Ying
    HU Dai Yu
    ZHANG Yan Ling
    LI Xiang Qun
    LI Liang
    [J]. Biomedical and Environmental Sciences, 2016, 29 (08) : 612 - 617
  • [10] Outcomes of extended duration therapy for drug-susceptible cavitary pulmonary tuberculosis
    Lee, Hyun
    Sohn, Jang Won
    Sim, Yun Su
    Shin, Tae Rim
    Kim, Dong-Gyu
    Choi, Hayoung
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
12345